The New York Times reports that some academic scientists and physicians are tired of the notation next to their names that indicates that they have accepted money from a drug, food, or medical device company. They now reject honoraria in hopes of restoring their good names. "It is not worth it to be under suspicion," says Brigham and Women's Peter Libby.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.